Huapont Life Science Co (SZSE:002004) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:002004 Huapont Life Science Co Ltd SZSE:002004
65 GF Score
Price ¥4.38
GF Value ¥4.43
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Huapont Life Science Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Huapont Life Science Co Valuation Rank Related Terms

SZSE:002004
65GF Score
Huapont Life Science Co Ltd SZSE:002004
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?

Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued. The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43. GuruFocus considers Huapont Life Science Co to be Fairly Valued.

Key valuation signals for SZSE:002004:

  • Valuation Rank:
  • GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Huapont Life Science Co Business Description

Address No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score

Get the complete analysis for SZSE:002004

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.38
Price
¥4.43
GF Value